Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Entrada Therapeutics
28 State Street, Suite 2303
Boston, MA 02109
Phone: 857-305-1825
www.entradatx.com

Entrada Therapeutics' mission is to treat devastating diseases through the intracellular delivery of biologics. Entrada's technology enables the efficient intracellular delivery of proteins, peptides and nucleic acids, thus allowing for the development of programs across several intracellular target classes. The Company's novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the delivery of molecules into the cytosol.

Key Contact
Name
Dipal Doshi
Title
President & CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
12/18/18 $59,000,000 Series A 5AM Ventures
Agent Capital
MPM Capital
MRL Ventures Fund
Roche Venture Fund
03/31/21 $116,000,000 Series B 5AM Ventures
CureDuchenne Ventures
Goldman Sachs
Greenspring Associates
Moore Strategic Ventures
MPM Capital
MRL Ventures Fund
Point72 Asset Management
Qatar Investment Authority
Redmile Group
TCG
Wellington Management Company


Featured Reading